US equities
|
SPCX
$147.79
▲+0.00%
MU
$896.07
▲+0.00%
NVDA
$216.47
▲+0.00%
TSLA
$373.71
▲+0.00%
SNDK
$1,365.38
▲+0.00%
SKHY
$139.79
▲+0.00%
AMD
$534.74
▲+0.00%
INTC
$91.69
▲+0.00%
SPCX
$147.79
▲+0.00%
MU
$896.07
▲+0.00%
NVDA
$216.47
▲+0.00%
TSLA
$373.71
▲+0.00%
SNDK
$1,365.38
▲+0.00%
SKHY
$139.79
▲+0.00%
AMD
$534.74
▲+0.00%
INTC
$91.69
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
NRX Pharmaceuticals, Inc. - Common Stock
(NQ:
NRXP
)
2.620
UNCHANGED
Delayed Quote
Updated: 4:00 PM EDT, Oct 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about NRX Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
19
20
Next >
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Second Quarter 2025 Financial Results and Provides Corporate Update
August 18, 2025
From
NRx Pharmaceuticals, Inc.
Via
GlobeNewswire
Insights Ahead: NRX Pharmaceuticals's Quarterly Earnings
↗
August 13, 2025
Via
Benzinga
From Novel Therapies To Treat Suicidal Bipolar Depression To Launching A Network Of Clinics, NRx Pharmaceuticals Is Getting Attention On Wall Street
August 13, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
From Novel Therapies To Treat Suicidal Bipolar Depression To Launching A Network Of Clinics, NRx Pharmaceuticals Is Getting Attention On Wall Street
August 13, 2025
Via
TheNewswire.com
Why Small-Cap Biotech NRx Pharmaceuticals Is Drawing Heavy Retail Buzz
↗
August 12, 2025
NRx said the FDA’s fast-track status makes NRX-100 eligible for the Commissioner’s National Priority Voucher program and the FDA’s Accelerated Approval pathway, and the company has already applied for...
Via
Stocktwits
$3 Billion Suicidal Depression Market May Soon be Accessible via FDA Fast Track Designation for Effective NRX 100 Drug Therapy: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
August 11, 2025
Via
Get News
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Second Quarter 2025 Financial Results on August 14, 2025
August 11, 2025
From
NRx Pharmaceuticals, Inc.
Via
GlobeNewswire
Loop Industries (NASDAQ: LOOP) – Roth Capital Bullish, CEO & Board Buy Big as Twist™ Gains Global Traction – More Stocks Inside
August 11, 2025
Via
AB Newswire
Topics
Economy
New to The Street Client NRx Pharmaceuticals (NASDAQ:NRXP) Secures FDA Fast Track Designation for NRX-100, Expanding Reach to 13 Million Americans Confronting Suicidal Ideation
August 11, 2025
Via
ACCESS Newswire
BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Fast Track Designation for NRX-100 in Treating Suicidal Ideation in Depression
August 11, 2025
Via
Investor Brand Network
New to The Street to Air Show #683 on Bloomberg, Featuring BioVie, FLOKI, PetVivo, and NRx Pharmaceuticals
August 09, 2025
Via
ACCESS Newswire
PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics(TM) Secures Florida Regulatory Clearance to Close Dura Medical Acquisition
August 08, 2025
Via
Investor Brand Network
Topics
Intellectual Property
Actions to Remove Benzethonium Chloride from Ketamine Products in Favor of Safer and Superior Option in $750 Million Market, Projected to Reach $3.35 Billion by 2034: NRx Pharmaceuticals, Inc.
August 05, 2025
Via
Get News
BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Petitions FDA to Ban Benzethonium Chloride from Ketamine Products
August 04, 2025
Via
Investor Brand Network
Topics
Intellectual Property
New to The Street Show #682 Premieres on Bloomberg Tonight Featuring Industry Leaders: DataVault, PetVivo, Health In Tech, FLOKI, and NRx Pharma Backed by National TV Commercials and Outdoor Campaigns Sponsored by MUSQ, ArriveAI, and Sustainable Green
August 01, 2025
Via
ACCESS Newswire
BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) CEO to Join Fireside Chat at BTIG Virtual Biotechnology Conference
July 29, 2025
Via
Investor Brand Network
New to The Street Show #680 to Air Saturday, July 26 at 6:30 PM EST on Bloomberg TV
July 25, 2025
Via
ACCESS Newswire
BioMedNewsBreaks – NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Charts Dual-Path for NRX-100
July 18, 2025
Via
Investor Brand Network
PsychedelicNewsBreaks – NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Positioning at the Forefront of Next-Gen Treatment
July 16, 2025
Via
Investor Brand Network
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Subsidiary to Acquire 49% Stake in Prominent Florida Neuropsychiatry Clinic
July 08, 2025
Via
Investor Brand Network
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Applies for FDA Commissioner’s National Priority Voucher for IV Ketamine NRX-100
June 27, 2025
Via
Investor Brand Network
Topics
Economy
Intellectual Property
BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics to Acquire 49% Stake in Leading Florida Psychiatry Clinic
June 26, 2025
Via
Investor Brand Network
$750 Million Ketamine Drug Market, Projected to Reach $3.35 Billion in 2034 Coming Withing Reach via New Commissioner’s National Priority Vouchers with Anticipated Approval by Year-End for: NRXP
June 24, 2025
Via
Get News
PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Taps IBN to Lead Corporate Communications Amid Drug Advancements and Subsidiary Launch
June 24, 2025
Via
Investor Brand Network
BioMedNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Applies for FDA Commissioner’s Priority Voucher for NRX-100 Ketamine Formulation
June 23, 2025
Via
Investor Brand Network
Topics
Intellectual Property
New to The Street Show #673 Airs Nationwide on Bloomberg TV - Saturday, June 21 at 6:30 PM EST Featuring FLOKI, NRX Pharmaceuticals (NASDAQ:NRXP), MUSQ - The Music ETF (NYSE:MUSQ), Health In Tech (NASDAQ:HIT), and Vita Bella
June 20, 2025
Via
ACCESS Newswire
New to The Street's Show #672 Airs Tonight on Fox Business Network at 10:30 PM EST
June 16, 2025
Via
ACCESS Newswire
BioMedNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Forms Investor Relations Partnership With astr Partners
June 16, 2025
Via
Investor Brand Network
New to The Street Episode #671 Airs Tonight on Bloomberg Television at 6:30 PM EST Featuring FLOKI, Arrive AI (NASDAQ: ARAI), Health In Tech (NASDAQ: HIT), Vita Bella, and NRX Pharmaceuticals (NASDAQ: NRXP)
June 14, 2025
Via
ACCESS Newswire
BioMedNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) and HOPE Therapeutics to Present at H.C. Wainwright Neuro Perspectives Conference
June 12, 2025
Via
Investor Brand Network
< Previous
1
2
3
4
5
6
7
8
9
...
19
20
Next >
